authors
- Breadner, D
- Liu, G
- Rothenstein, J
- Wheatley-Price, P
- Bains, P
- Cheng, S
- Wang, Y
- Sun, S
- Mithoowani, H
- Juergens, Rosalyn
- Cheema, P
- Vincent, M
OCELOT - Osimertinib then Chemotherapy in EGFR plus Lung Cancer with Osi Third-line Rechallenge and Osimertinib for Uncommon EGFRm in 1L
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- September 1, 2022
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Thoracic Oncology Journal